Literature DB >> 8056199

Developmental toxicology studies of fluoxetine hydrochloride administered orally to rats and rabbits.

R A Byrd1, J K Markham.   

Abstract

Pregnant Fischer 344 rats were given fluoxetine orally at dose levels of 0, 2, 5, or 12.5 mg/kg on Gestation Days (GD) 6-15; pregnant Dutch Belted rabbits were given 0, 2.5, 7.5, or 15 mg/kg orally on GD 6-18. Cesarean sections were performed on rats and rabbits on GD 20 and 28, respectively. In rats, maternal toxicity was indicated at 12.5 mg/kg by depression of weight gain and food consumption. Fetal viability, weight, and morphology were not affected at any dose level. Maternal and developmental No Observed Adverse Effect Levels (NOAELs) in the rat were 5 and 12.5 mg/kg, respectively. In rabbits, weight loss occurred at 2.5, 7.5, and 15 mg/kg. Food consumption was also depressed at 7.5 and 15 mg/kg; abortions and maternal mortality occurred secondarily to anorexia and cachexia at 15 mg/kg. Fetal viability, weight, and morphology were not affected at any dose level. A NOAEL for maternal effects was not established in the rabbit; the NOAEL for developmental effects in the rabbit was 15 mg/kg. Based on these data, fluoxetine did not exhibit any toxicity toward the developing rat or rabbit conceptus at doses that were maternally toxic.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8056199     DOI: 10.1006/faat.1994.1058

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  8 in total

Review 1.  Prenatal antidepressant exposure: clinical and preclinical findings.

Authors:  Chase H Bourke; Zachary N Stowe; Michael J Owens
Journal:  Pharmacol Rev       Date:  2014-02-24       Impact factor: 25.468

2.  Selective Serotonin Re-uptake Inhibitors (SSRIs) Induced Weight Changes: A Dose and Duration Dependent Study on Albino Rats.

Authors:  Alka Aggarwal; S L Jethani; R K Rohatgi; Juhi Kalra
Journal:  J Clin Diagn Res       Date:  2016-03-01

Review 3.  Safety of selective serotonin reuptake inhibitors in pregnancy.

Authors:  Sura Alwan; Jan M Friedman
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

4.  Long-term effects of fluoxetine or vehicle administration during pregnancy on behavioral outcomes in guinea pig offspring.

Authors:  Raphael Vartazarmian; Saima Malik; Glen B Baker; Patricia Boksa
Journal:  Psychopharmacology (Berl)       Date:  2004-09-10       Impact factor: 4.530

5.  Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.

Authors:  Orna Diav-Citrin; Svetlana Shechtman; Dafna Weinbaum; Rebecka Wajnberg; Meytal Avgil; Elena Di Gianantonio; Maurizio Clementi; Corinna Weber-Schoendorfer; Christof Schaefer; Asher Ornoy
Journal:  Br J Clin Pharmacol       Date:  2008-07-11       Impact factor: 4.335

6.  Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat?

Authors:  Orna Diav-Citrin; Asher Ornoy
Journal:  Obstet Gynecol Int       Date:  2011-12-10

7.  Teratogenic effects of coadministration of fluoxetine and olanzapine on rat fetuses.

Authors:  Azam Bakhtiarian; Nasrin Takzare; Mehdi Sheykhi; Narges Sistany; Farahnaz Jazaeri; Mario Giorgi; Vahid Nikoui
Journal:  Adv Pharmacol Sci       Date:  2014-01-15

Review 8.  Use of Prescribed Psychotropics during Pregnancy: A Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes.

Authors:  Catherine E Creeley; Lisa K Denton
Journal:  Brain Sci       Date:  2019-09-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.